Mettler Toledo Introduces Mechanical Analyzer - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Mettler Toledo Introduces Mechanical Analyzer


The Excellence Dynamic Mechanical Analyzer DMA 1, introduced by Mettler Toledo at Pittcon 2013, offers six different deformation modes to gauge materials performance. The instrument can handle multiple dynamic and static measurements to characterize viscoelasticity, glass transition, softening, crystallization, and phase transformation, according to the press announcement.

Users can set the sample arm and analysis head at multiple angles based on sample nature and geometry. Rapid cooling to as low as -190 ºC with minimal liquid nitrogen consumption also helps improve sample throughput, reduce costs, and improve operator safety.

The linear variable differential transformer (LVDT) measures changes in length over a measurement range of ±1 mm with a mean resolution of 2 nm. The DMA 1 also offers the ability to operate in liquids or at specific relative humidity levels.

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
32%
Breakthrough designations
11%
Protecting the supply chain
37%
Expedited reviews of drug submissions
11%
More stakeholder involvement
11%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
Sandoz Wins Biosimilar Filing Race
NIH Translational Research Partnership Yields Promising Therapy
Clusters set to benefit from improved funding climate but IP rights are even more critical
Supplier Audit Program Marks Progress
FDA, Drug Companies Struggle with Compassionate Use Requests

Click here